Fig. 2From: Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinomaResults of an LC–MS/MS analysis for TMED9. a Representative data showing the sequence of the trypsinized peptide, R.QLVEQVEQIQK.E, which was matched to TMED9 in hepatocellular carcinoma (HCC) patient samples. b Matching B-ions and Y-ions (red) fragments were recorded to identify the sequence of TMED9. The retained charge on the amino-terminal part of the peptide is shown as B-ions, and the retained charge on the carboxyl-terminal part of the peptide is Y-ionsBack to article page